StockData
Lakewood-Amedex Biotherapeutics Inc. logo

Lakewood-Amedex Biotherapeutics Inc. (LABT) stock

LABTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$0.21−0.00 (-2.23%)

Close on Nov 17, 2026Market cap $508.30KP/E –Yield –

Lakewood-Amedex Biotherapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$0.62–
Q2 FY2026Jun 30, 2026-$2.75–
Q1 FY2026Mar 31, 2026-$0.20–
Q3 FY2025Sep 30, 2025-$3.46–
Q2 FY2025Jun 30, 2025-$1.66–
Q1 FY2025Mar 31, 2025-$0.15–

More Lakewood-Amedex Biotherapeutics figures

See a number that looks wrong?